The electrochemical reduction of 1,4-bis-(2-[(2-hydroxyethyl)-amino] ethylamino)-anthracenedione and daunomycin: biochemical significance in superoxide formation.
D000818:Animals; D000880:Anthraquinones / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003630:Daunorubicin / Q000494:pharmacology*; D004563:Electrochemistry; D004578:Electron Spin Resonance Spectroscopy; D007700:Kinetics; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism*; D008942:Mitoxantrone; D010084:Oxidation-Reduction; D010100:Oxygen / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects*; D051381:Rats; D013329:Structure-Activity Relationship; D013481:Superoxides / Q000378:metabolism*
D000880:Anthraquinones; D000970:Antineoplastic Agents; D013481:Superoxides; D008942:Mitoxantrone; D010100:Oxygen; D003630:Daunorubicin